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a  b  s  t  r  a  c  t
Osteocytes  are  organized  in functional  syncytia  collectively  referred  to  as  the  osteocytic
lacunar–canalicular  system  (OLCS).  The  osteocytes  are  interconnected  through  gap  junctions  between
their  cytoplasmic  processes,  which  pass  through  narrow  passageways  referred  to  as  osteocytic  canali-
culi.  There  are  two possible  ways  molecules  can  be  transported  throughout  the  OLCS:  via the  cytoplasmic
processes  and  their  gap  junctions,  and  via  the pericellular  space  in  the  osteocytic  canaliculi.  Transport  of
minerals  and  small  molecules  through  a spatially  well-organized  OLCS  is  vital for  bone  mineral  homeosta-
sis,  mechanosensing,  and  bone  remodeling  control.  Recently,  osteocyte-derived  molecules  –  sclerostin,clerostin
GF23
one remodeling
dentin  matrix  protein-1,  ﬁbroblast  growth  factor  23 (FGF23)  – have  been  put in  evidence  as they  may
be  related  to  osteocytic  functions  such  as  mechanosensing,  regulation  of  bone  remodeling,  and  so  forth.
FGF23  regulates  serum  phosphate  concentration  by  affecting  renal  function,  while  sclerostin  can  inhibit
osteoblastic  activities.  In  our observations,  FGF23  and  sclerostin  synthesis  seemed  to  be  associated  with
the  spatial  regularity  of  the  OLCS.  This  review  will introduce  our  recent  morphological  studies  on  the
regularity  of  OLCS  and  the  synthesis  of  osteocyte-derived  FGF23  and  sclerostin.© 2012 Japanese Stomatological Society. Published by Elsevier Ltd. All rights reserved.
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Osteocytes, the most abundant cells in bone, are at the center
of bone turnover control as they establish the network through
which osteoblasts and bone lining cells communicate. All osteo-
cytes lie within osteocytic lacunae and connect to other osteocytes
and to osteoblasts on the bone surface. Osteocytes are embed-
ded in the bone matrix, and are derived from osteoblasts that got
evier Ltd. All rights reserved.
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Fig. 1. The ultrastructure of osteocytes depending on the site and on the interval since embedding into the bone matrix. Panel A shows a recently embedded osteocyte
(ocy) connected to an osteoblast (ob) by its cytoplasmic processes (arrows). This osteocyte has abundant rough endoplasmic reticulum (rER) and shares ultrastructural
similarities with osteoblasts. In panel B, osteocytes close to the bone surface but embedded into mineralized matrix tend to have rER and are surrounded by the rough walls
of  the osteocytic lacuna. As shown in the right-hand panel, there are collagen ﬁbrils in the pericellular space in the osteocytic lacuna. In contrast, as shown in panels C and

























migniﬁcant. Please note the nucleus of osteocyte in D was  much more condensed t
arrowheads in C and D), indicate the absence of bone deposition. Bar: A–D, 1 m.
trapped” within the bone matrix. Depending on the site and on
he interval since the embedding, osteocytic ultrastructure can vary
igniﬁcantly (Fig. 1). Recently embedded osteocytes have abundant
ough endoplasmic reticulum (rER) and Golgi apparatus, indicat-
ng some residual bone formation capacity. Osteocytes close to the
one surfaces have rER, and their osteocytic lacunae have rough
alls, suggesting that osteocytes embedded in the superﬁcial bone
ayers may  still be capable of synthesizing bone matrix. Aarden
t al. termed osteocytes located in osteoid and those embedded
n recently mineralized matrix as osteoid osteocytes and young
steocytes, respectively [1]. In contrast, osteocytes embedded in
he deeper portion of matrix or those that have been buried for a
ong time (mature osteocytes) show fewer cell organelles with the
ucleus becoming more prominent.
The process of osteocyte embedding in bone is not at all random.
steocytes act as a functional group, since their cytoplasmic pro-
esses are connected through gap junctions [2–4]. Such a network
f cytoplasmic processes permits the passage of small cytoplas-
ic molecules from one osteocyte to the next. In addition, the
ericellular space (annular space) in the osteocytic canaliculi may
erve as an alternative transport path (Fig. 2). The diffusion coef-
cient of ﬂuorescein in the pericellular space has been shown to
e similar to diffusion coefﬁcients measured for comparably sized
olecules in cartilage matrix [5]. Through these possible paths,at seen in C. The electron dense lines on the wall of lacunae, the lamina limitans
embedded  osteocytes communicate and establish the osteocytic
lacunar–canalicular system (OLCS) [1,6,7]. The three-dimensional
OLCS has been examined in vivo [8], and our group has recently
demonstrated that, in mice, the OLCS becomes progressively more
regular as the individual grows [9].
For the OLCS to function properly, its anatomic arrangement has
to be correct. In mature, cortical bone, osteocytic bodies parallel
the bone surface and extend their cytoplasmic processes perpen-
dicularly to it (Fig. 3) [10]. This regularity may  relate with the
direction of the collagen bundles: while the longitudinal axis of
the osteocytes parallels the direction of the collagen ﬁbrils, their
cytoplasmic processes are perpendicular to them. The regular OLCS
may  enable the osteocytes to sense mechanical loading and efﬁ-
ciently transport small molecules via their cytoplasmic processes
and through the pericellular space of their canaliculi. Bone disease,
on the other hand, may signiﬁcantly affect the arrangement of the
OLCS. In human osteomalacia, haphazardly connected, non-regular
OLCS are seen, and in the late stage of osteoporosis, a remarkable
compromise of connectivity and regularity of that system is present
[7].In this review, we  will introduce and elaborate on morphologi-
cal aspects of osteocytic function, especially the biological function
of the regularly arranged OLCS and the pivotal roles of osteocyte-
derived factors in bone mineralization.
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Fig. 2. Cellular network of osteocytes and the pericellular space of osteocytic canaliculi. (A–C) Images of scanning electron microscopic observation on the cellular network of
osteocytes (ocy) after elimination of extracellular bone matrices. As shown in (A), ﬂattened osteocytes in the endosteal region of cortical bone lies parallel to the bone surface,
extending their cytoplasmic processes perpendicularly to it. However, the periosteal region of the cortical bone (B) reveals randomly oriented osteocytes extending their
processes in all directions. Please note the bifurcation of osteocytic processes (arrows) when observed at a higher magniﬁcation (C). Panels D and E show the transmission
electron microscopic images of pericellular space, or annular space in the osteocytic canaliculi (D is an image obtained from mineralized bone, while E shows demineralized
osteocytic canaliculi). Please note that there are two possible pathways for molecular transport, one formed by the cytoplasmic processes, and the other being the pericellular











e. Putative function of osteocytic osteolysis
Can an osteocyte regulate the mineralization of the bone matrix
hat encloses it? It is possible that osteocytes respond to parathy-
oid hormone (PTH) or to a low calcium diet by altering serum
alcium levels. This phenomenon was reported a hundred years
go by Recklinghausen [11] and by Kind [12], and in the 1960s,
élanger proposed a new notion of “osteocytic osteolysis” [13]. Six
ours after injection of human PTH (1–34) into the jugular vein of
ice, we observed enlarged osteocytic lacunae in the cortical bone
ith regular OLCS. One may  question wonder whether osteoclasts
an create such enlargement by secreting acids and proteolytic
nzymes, which may  erode the lacunar matrix. In order to addressthe  issue at hand, it seems necessary to verify the occurrence of
enlarged lacunae in mice lacking osteoclasts. In addition, some
researchers may  attribute the acute elevation of serum calcium
levels after PTH injection to osteocytic osteolysis, while others may
question whether such a raise may  result from stimulated renal cal-
cium reabsorption. Some ﬁndings suggest possible mechanisms for
osteocytic osteolysis, e.g., synthesis of tartrate-resistant acid phos-
phates by osteocytes [14], enlarged osteocytic lacunae and acid
phosphates activity in osteocytes after continuous infusion of PTH
for 4 weeks [15], as well as synthesis of matrix metalloproteinase-2
by osteocytes [16]. More recently, the groups of Teti and Bonewald
reported osteocytic remodeling of the perilacunar and pericanalic-
ular matrix [17,18].
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Fig. 3. Histological imaging of osteocytic lacunar–canalicular system using parafﬁn sections. Panels A, B and C, D are silver impregnation modiﬁed of Bodian’s method and











thase contrast images of the distribution of osteocytes (ocy) and their canaliculi. In
xtended the cytoplasmic processes perpendicularly to it. However, as shown in B 
econdary trabeculae. Bar: A–D, 30 m.
. Possible role of osteocytes in mineral transport and as
ransducers  of mechanical strains into biochemical signals
While  the true function of the osteocytic osteolysis is still under
iscussion, the fact that minerals and other small molecules are
arried through the OLCS serves as the basis for assuming that
steocytes might be intimately involved in chemical transduction
5,19,20]. Regarding mineral transport, ablation of osteocytes in
ransgenic mice expressing osteocyte-speciﬁc receptor for diph-
heria toxin, strongly indicated that osteocytes control mineral
rafﬁc in bone [21]. After diphtheria toxin injection, transgenicrtical bone (A and C), osteocytes’ bodies were parallel to the bone surface, but they
, the distribution of osteocytes and their canaliculi was similar in the metaphyseal
mice  showed many empty lacunae, indicating osteocyte death.
Curiously, trabeculae were shortened after toxin injection, and the
cortical bones started to show broad demineralized areas in the
periphery of empty osteocytic lacunae. It seems that disruption of
osteocytic function leads to some type of bone mineral shortage.
Another  accepted theory for osteocytic function places these
cells as transducers of mechanical strains into biochemical sig-
nals that affect communication among osteocytes and between
osteocytes and osteoblasts [6,19,22,23]. Bone remodeling appears
to have three different aspects: (1) balance of essential serum min-
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f load-related microdamage [24]. While the ﬁrst aspect does not
eed site-dependent remodeling, the other two  do require that
peciﬁcity. This concept is named “targeted bone remodeling” [25].
he proposed cellular mechanism of targeted bone remodeling
egards osteocytes as sensors for microdamage in bone [26–28].
nce damage is detected, osteocytes would undergo apoptosis,
riggering the resorption of the damaged region [29–31]. There
re many reports on osteocytic apoptosis and accumulated micro-
amage as important factors for initiating new remodeling sites
26,27,32–34]. It seems likely that osteocytic apoptosis and micro-
amage disturb the signals carried throughout the OLCS, leading to
ignaling misinterpretation by osteocytes and osteoblasts and ini-
iation of targeted bone remodeling. An intact OLCS seems crucial
or molecular transport among osteocytes, and may  be important
or mechanosensing and bone remodeling control.
We  have shown that osteocytes embedded in remodeled bone
ere ﬂat and extended their cytoplasmic processes perpendicu-
arly to the longitudinal axis of trabecular and cortical bones (Fig. 3).
sing biomechanical simulation analyses, McCreadie et al. [35]
emonstrated that strains were higher in elongated cells com-
ared to less elongated ones, when load parallels the long axis
f the lacuna. Also, ﬁnite element models showed that longer,
hinner cells have higher maximum strains [36]. Flattened osteo-
ytes are found among collagen bundles, which run parallel to each
ther and, therefore, may  not disturb the seam of collagen bundles
n compact bones. Orderly distributed osteocytes and osteocytic
rocesses, when geometrically harmonized with the surround-
ng collagenous architecture, may  be very effective in recognizing
echanical loading. In addition, a regular OLCS may efﬁciently
ransport small molecules from one osteocyte to others, and to
steoblasts as well [6,19,20,37]. Irregularly distributed osteocytic
rocesses, on the other hand, may  not be so efﬁcient when it comes
o recognizing the direction and the intensity of mechanical load-
ng. The notion that bone remodeling occurs as the skeleton adapts
tself to its mechanical environment [24,25] supports our idea that
steocytes develop a well-organized OLCS as normal bone remod-
ling progresses.
.  Regulation of bone minerals by mediating
steocytes-derived factors
Osteocyte-derived molecules were recently highlighted
ecause these molecules may  reﬂect osteocytic function respond-
ng to mechanosensing, regulation of bone remodeling and so
orth. Dentin matrix protein-1 (DMP-1) was shown to be a bone
atrix protein expressed in osteocytes (Fig. 4A–C), and has been
ssumed to play a pivotal role in bone mineral homeostasis, due
o its high calcium-binding afﬁnity [38,39]. Another osteocyte-
erived factor, sclerostin, is a glycoprotein encoded by the SOST
ene [40], and was reported to bind the LRP5/6 receptor, thereby
ntagonizing Wnt  signaling and increasing -catenin degradation
41,42]. Sclerostin has been reported as a negative regulator of
steoblastic bone formation [40,43–45]: Sclerostin secreted by
steocytes may  pass through the osteocytic canaliculi and inhibit
one-lining osteoblasts. Fibroblast growth factor (FGF) 23, which
s also an osteocyte-derived factor (Fig. 4D–F), modulates serum
hosphate concentration, by co-operating in kidney [46]. Thus,
ecently highlighted factors such as FGF23, sclerostin, and DMP-1
ould provide clues for better understanding for osteocytic
unction..1. Role of osteocyte-derived sclerostin in bone remodeling
Sclerostin, which is secreted by osteocytes, passes through
steocytic canaliculi and inhibits osteoblasts, and therefore isernational 9 (2012) 1– 8 5
characterized as a factor that regulates bone formation. We  have
examined the distribution of sclerostin and OLCS in long bones
of mice lacking osteoprotegerin (OPG) [47], a decoy receptor for
the receptor activator of the nuclear factor B ligand (RANKL).
OPG has been characterized as an inhibitor of osteoclastogene-
sis [48]. OPG-deﬁcient mice showed accelerated bone remodeling
and an irregular OLCS. While DMP-1 was  found in all osteocytes
in the OPG-deﬁcient bone, sclerostin reactivity was  signiﬁcantly
diminished in OPG-deﬁcient epiphyses and cortical bone. Sclerostin
appears to be synthesized speciﬁcally once osteocytes possess a
regular OLCS, for example in normal, mature cortical bone. It has
been suggested that PTH administration inhibits sclerostin syn-
thesis by osteocytes, thereby allowing for active bone remodeling
[44].
By examining the mesial region of the mandibular interradic-
ular septum in ovariectomized rats, we attempted to elucidate
whether estrogen deﬁciency would affect the synthesis of scle-
rostin by means of accelerating bone resorption or through a more
direct effect on the estrogen receptors in osteocytes (unpublished
data). The mesial region of ovariectomized interradicular septa
showed an increased number of osteoclasts with intense RANKL
labeling, as well as widespread absence of sclerostin-positive osteo-
cytes. Accelerated bone remodeling induced by estrogen deﬁciency,
rather than having a direct effect through the estrogen receptors
in osteocytes, appeared to inhibit sclerostin expression by osteo-
cytes in the mesial region of interradicular septa. These ﬁndings
imply that bone remodeling or its participating cells, osteoblasts
and osteoclasts, would primarily affect sclerostin synthesis.
Recently, two  reports demonstrated that osteocytes express
high amounts of RANKL and by doing so support osteoclastic dif-
ferentiation; meanwhile, the authors believe that RANKL produced
by osteoblasts seems not to contribute to adult bone remodeling
[49,50]. This is a radical shift from the presently prevailing knowl-
edge of osteoclastogenesis. It seems necessary to examine in detail
whether osteoclasts differentiate only after triggered by osteocyte-
derived RANKL. Also, one may consider how matrix-embedded
osteocytes could affect osteoclast precursors that lie distant from
bone surfaces. Yet, examining the involvement of osteocytes in
osteoclastogenesis is crucial for new breakthroughs in bone biol-
ogy, and these two  reports may  provide a new horizon in the ﬁeld.
4.2. Distribution of FGF23 in the OLCS
FGF23 was originally reported as a phosphaturic factor in auto-
somal dominant hypophosphatemic rickets [51], tumor-induced
osteomalacia [52], McCune-Albright syndrome/ﬁbrous dysplasia
[53], familial tumoral calcinosis [54], and in X-linked hypophos-
phatemic rickets [55]. Although FGF23 mRNA is found in several
tissues [51,52,54], this molecule is most abundantly expressed
in bone [56]. FGF23 serves as a phosphaturic agent that inhibits
1,25(OH)2D3 production and the function of sodium/phosphate co-
transporter II (NaPiII), which inhibits reabsorption of phosphates
in the proximal renal tubules [57–59]. Investigations on the bio-
logical functions of FGF23 have broadened the understanding of
the systemic regulation of phosphate homeostasis, as well as the
knowledge about maintaining mineralization in the bone matrix
[60].
We have observed FGF23-immunopositive osteocytes in
disease-free secondary trabeculae and cortical bone with regu-
larly oriented OLCS: FGF23 appears to be synthesized mainly by
osteocytes forming regularly distributed OLCS in mature bone
that had been remodeled (Fig. 4D–F) [10]. Alternatively, intense
immunopositivity for FGF23 in metaphyseal primary trabeculae
with irregular OLCS could not be veriﬁed. Mature bone could,
therefore, serve as an organ regulating serum phosphorus lev-
els. Although preliminary, one of our recent experiments hinted
6 M.  Sasaki et al. / Oral Science International 9 (2012) 1– 8
Fig. 4. Distribution of dentin matrix protein (DMP-1) and ﬁbroblast growth factor (FGF) 23 in the epiphysis (epi) and metaphysis (meta). Panel A shows the immunolocalization
of DMP-1 (brown color) throughout the femoral epiphysis and metaphysis. DMP-1 positivity is found in osteocytes (ocy) and their lacunae and canaliculi of both the primary
(B)  and secondary (C) metaphyseal trabeculae. In contrast, as shown in panel D, while FGF23 positive osteocytes (red) are prominent in the epiphysis, hardly any positivity is
























hn the secondary trabecules tend to exhibit relatively intense FGF23 immunoreacti
nterpretation of the references to color in this ﬁgure legend, the reader is referred 
n enhancement of FGF23 synthesis by osteocytes after 2 weeks
f PTH administration. However, PTH administration also accel-
rated bone remodeling and formation of an irregular OLCS. PTH
ay induce FGF23 synthesis in osteocytes even when the OLCS
s malformed; also, PTH could directly attenuate phosphate reab-
orption, but also by inhibiting NaPiII in the proximal renal tubules.
hese preliminary ﬁndings further support an important role of the
steocytes in phosphate homeostasis.
.3. Disrupted osteocytic function in klotho-deﬁcient mice
The  klotho gene is involved in multiple aging phenotypes and
ge-related disorders. Klotho-deﬁcient mice develop normally until
 weeks of age, then become less active and ultimately die by 8–9
eeks of age [61]. The defect in klotho gene causes osteoporosis,
kin atrophy, ectopic mineralization (vascular calciﬁcation), pul-
onary emphysema, gonadal dysplasia, and defective hearing in
ice – all of which also appear in human aging. Recently, two
lotho proteins have been recognized: transmembrane klotho and
irculating klotho. The transmembrane klotho is a main co-receptor
or the FGF23 signaling pathways [46,62,63]. Circulating klotho, on
he other hand, regulates the activity of multiple glycoproteins on
he cell surface, including ion channels and insulin growth factor-
 receptor [64]. Since klotho was shown to regulate phosphate
omeostasis as an obligate co-receptor for FGF23, its deﬁciencyodiﬁed from Ubaidus et al. [10]. Bar: A and D, 100 m; B, C, E, and F, 30 m.  (For
 web version of the article.)
could  lead to defective FGF23 signaling, consequently accelerating
phosphate reabsorption in kidney [46,57–59,62]: Klotho-deﬁcient
mice feature high serum calcium, phosphorus [61,65], and osteo-
protegerin [66,67] levels.
The abnormal histology found in klotho-deﬁcient mice has
been attributed to a disrupted FGF23-klotho axis. We,  how-
ever, postulated that klotho deﬁciency might also affect bone
in a way not linked to the FGF23-klotho axis. We  have
observed that klotho-deﬁcient primary metaphyseal trabeculae
were excessively mineralized, probably due to markedly increased
concentrations of calcium and phosphate, while the secondary
metaphyseal trabeculae showed defective mineralization [68,69].
Using electron probe microanalysis, we  demonstrated higher
and lower contents of calcium and phosphorus in primary and
secondary metaphyseal trabeculae of klotho-deﬁcient mice, respec-
tively.
More recently, we found matrix proteins – matrix Gla proteins
(MGP), DMP-1, and osteocalcin with a high afﬁnity to hydroxyap-
atite – localized in the excessively mineralized osteocytic lacunae
of klotho-deﬁcient bone, indicative of dying osteocytes [70]. These
ﬁndings suggest that osteocalcin and MGP  are ectopically synthe-
sized in klotho-deﬁcient osteocytes, which also synthesize a large
amount of DMP-1. Consequently, the osteocytic lacunae are ﬁlled
with mineralized crystals and osteocytic function is disrupted. It
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n klotho-deﬁcient osteocytes in a manner independent from the
GF23-klotho axis.
.  Conclusion
The regularly arranged OLCS is a functional syncytia where
GF23 and sclerostin expression is observed. The regularity of the
LCS seems to be established by physiological bone remodeling,
hich secures bone maturation.
cknowledgment
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